Cypress Bioscience, Inc. Announces Fourth Quarter and Fiscal Year End 2005 Results
Cypress Bioscience, Inc. Announces Fourth Quarter and Fiscal Year End 2005 Results
SAN DIEGO----March 15, 2006--Cypress Bioscience, Inc. today announced its financial results for the fourth quarter and year ended December 31, 2005. For the quarter ended December 31, 2005, the Company reported a net loss of approximately $1.8 million or $0.06 per share basic and diluted compared to a net loss of approximately $2.5 million or $0.08 per share basic and diluted for the
Technorati Tags:
fibromylagia treatment